Researchers tested KCL-286 in Alzheimer’s models, finding it reduced DNA damage and inflammation. The drug targets retinoic ...

Immunic, Inc. , a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, today announced participation in the following investor conferences in ...

The world-renowned academic institution has nothing to say in response to a six-month investigation by Byline Times raising ...

Renew Biotechnologies today announced the consolidation of Wasatch BioLabs and Resonant under the Renew Biotechnologies brand, creating a unified platform to advance sequencing-based diagnostics, ...

Anne Glover ’78 traces her journey from shop-floor foreman to deep-tech investor and discusses the challenges facing the UK ...

Class Disrupted is an education podcast featuring author Michael Horn and Futre’s Diane Tavenner in conversation with ...

A drug, that has previously been shown to be safe and tolerated by humans, reduces multiple disease-linked features of Alzheimer's in a mouse model of the disease. Neuroscientists from King's College ...

During the August 2026 solar eclipse, scientists will be rushing to gather data on the sun, but even if you aren't a ...

"Complex chemical processes are essential for making DNA." This long-held assumption in the field of biotechnology has been ...

Scientists have created a silicon chip that can write dozens of DNA sequences simultaneously using electricity and ...

The DNA in a single cup of water can track wildlife, monitor pollution and survey pathogens in waterways and their ...

Researchers from UNSW Sydney have built the first artificial protein motor capable of taking controlled, directional steps ...